Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src

Journal of Cell Science

Volumn 126, Issue 2, 2013, Pages 625-637

  Ishibashi, Kenichi ^a   Fukumoto, Yasunori ^a   Hasegawa, Hitomi ^a   Abe, Kohei ^a   Kubota, Shoichi ^a   Aoyama, Kazumasa ^a   Kubota, Sho ^a   Nakayama, Yuji ^a   Yamaguchi, Naoto ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

EGFR; ErbB4; Histone modification; Nuclear translocation; Src family tyrosine kinases

Indexed keywords

BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HISTONE H3; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE P60; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMATIN STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE REPRESSION; GROWTH INHIBITION; HISTONE MODIFICATION; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR SIZE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; HISTONES; HUMANS; LYSINE; NEUREGULIN-1; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84876082335     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.116277     Document Type: Article

References (69)

1. Agger, K., Cloos, P. A., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Canaani, E., Salcini, A. E. and Helin, K. (2007). UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731-734.
2. Aoyama, K., Fukumoto, Y., Ishibashi, K., Kubota, S., Morinaga, T., Horiike, Y., Yuki, R., Takahashi, A., Nakayama, Y. and Yamaguchi, N. (2011). Nuclear c-Ablmediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation. Exp. Cell Res. 317, 2874- 2903.
3. Biscardi, J. S., Maa, M. C., Tice, D. A., Cox, M. E., Leu, T. H. and Parsons, S. J. (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335-8343.
4. Bjorge, J. D., Bellagamba, C., Cheng, H. C., Tanaka, A., Wang, J. H. and Fujita, D. J. (1995). Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms. J. Biol. Chem. 270, 24222-24228.
5. Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L. and Courtneidge, S. A. (2000). SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20, 9018-9027.
6. Cans, C., Mangano, R., Barilá , D., Neubauer, G. and Superti-Furga, G. (2000). Nuclear tyrosine phosphorylation: the beginning of a map. Biochem. Pharmacol. 60, 1203-1215.
7. Carpenter, G. (2003). ErbB-4: mechanism of action and biology. Exp. Cell Res. 284, 66-77.
8. Chen, I. P., Henning, S., Faust, A., Boukamp, P., Volkmer, B. and Greinert, R. (2012). UVA-induced epigenetic regulation of P16(INK4a) in human epidermal keratinocytes and skin tumor derived cells. Photochem. Photobiol. Sci. 11, 180-190.
9. Dawson, M. A., Bannister, A. J., Göttgens, B., Foster, S. D., Bartke, T., Green, A. R. and Kouzarides, T. (2009). JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 461, 819-822.
10. Dikic, I. and Giordano, S. (2003). Negative receptor signalling. Curr. Opin. Cell Biol. 15, 128-135.
11. Dittmann, K., Mayer, C., Kehlbach, R. and Rodemann, H. P. (2008). Radiationinduced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol. Cancer 7, 69.
12. Egeblad, M., Mortensen, O. H., van Kempen, L. C. and Jäättelä, M. (2001). BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells. Biochem. Biophys. Res. Commun. 281, 25-31.
13. Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C. and Weinberg, R. A. (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65.
14. Fukumoto, Y., Obata, Y., Ishibashi, K., Tamura, N., Kikuchi, I., Aoyama, K., Hattori, Y., Tsuda, K., Nakayama, Y. and Yamaguchi, N. (2010). Cost-effective gene transfection by DNA compaction at pH 4.0 using acidified, long shelf-life polyethylenimine. Cytotechnology 62, 73-82.
15. Gilmore-Hebert, M., Ramabhadran, R. and Stern, D. F. (2010). Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways. Mol. Cancer Res. 8, 1388-1398.
16. Hubbard, S. R. and Till, J. H. (2000). Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373-398.
17. Iida, M., Brand, T. M., Campbell, D. A., Li, C. and Wheeler, D. L. (2013). Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor. Oncogene 32, 759-767.
18. Ikeda, K., Nakayama, Y., Togashi, Y., Obata, Y., Kuga, T., Kasahara, K., Fukumoto, Y. and Yamaguchi, N. (2008). Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity. Exp. Cell Res. 314, 3392-3404.
19. Jehn, B., Costello, E., Marti, A., Keon, N., Deane, R., Li, F., Friis, R. R., Burri, P. H., Martin, F. and Jaggi, R. (1992). Overexpression of Mos, Ras, Src, and Fos inhibits mouse mammary epithelial cell differentiation. Mol. Cell. Biol. 12, 3890- 3902.
20. Jenuwein, T. and Allis, C. D. (2001). Translating the histone code. Science 293, 1074- 1080.
21. Ju, D. S., Kim, M. J., Bae, J. H., Song, H. S., Chung, B. S., Lee, M. K., Kang, C. D., Lee, H. S., Kim, D. W. and Kim, S. H. (2007). Camptothecin acts synergistically with imatinib and overcomes imatinib resistance through Bcr-Abl independence in human K562 cells. Cancer Lett. 252, 75-85.
22. Kasahara, K., Nakayama, Y., Ikeda, K., Fukushima, Y., Matsuda, D., Horimoto, S. and Yamaguchi, N. (2004). Trafficking of Lyn through the Golgi caveolin involves the charged residues on alphaE and alphaI helices in the kinase domain. J. Cell Biol. 165, 641-652.
23. Kasahara, K., Nakayama, Y., Kihara, A., Matsuda, D., Ikeda, K., Kuga, T., Fukumoto, Y., Igarashi, Y. and Yamaguchi, N. (2007a). Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes/lysosomes. Exp. Cell Res. 313, 2651-2666.
24. Kasahara, K., Nakayama, Y., Sato, I., Ikeda, K., Hoshino, M., Endo, T. and Yamaguchi, N. (2007b). Role of Src-family kinases in formation and trafficking of macropinosomes. J. Cell. Physiol. 211, 220-232.
25. Kaushansky, A., Gordus, A., Budnik, B. A., Lane, W. S., Rush, J. and MacBeath, G. (2008). System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Chem. Biol. 15, 808-817.
26. Kikuchi, I., Nakayama, Y., Morinaga, T., Fukumoto, Y. and Yamaguchi, N. (2010). A decrease in cyclin B1 levels leads to polyploidization in DNA damage-induced senescence. Cell Biol. Int. 34, 645-653.
27. Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A. and Soriano, P. (1999). Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18, 2459-2471.
28. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705.
29. Kuga, T., Nakayama, Y., Hoshino, M., Higashiyama, Y., Obata, Y., Matsuda, D., Kasahara, K., Fukumoto, Y. and Yamaguchi, N. (2007). Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells. Arch. Biochem. Biophys. 466, 116-124.
30. Li, H., Lee, T. H. and Avraham, H. (2002). A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J. Biol. Chem. 277, 20965-20973.
31. Linggi, B. and Carpenter, G. (2006). ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol. 16, 649-656.
32. Long, W., Wagner, K. U., Lloyd, K. C., Binart, N., Shillingford, J. M., Hennighausen, L. and Jones, F. E. (2003). Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130, 5257-5268.
33. Määttä, J. A., Sundvall, M., Junttila, T. T., Peri, L., Laine, V. J., Isola, J., Egeblad, M. and Elenius, K. (2006). Proteolytic cleavage and phosphorylation of a tumorassociated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol. Biol. Cell 17, 67-79.
34. Mandal, M., Powers, S. E., Maienschein-Cline, M., Bartom, E. T., Hamel, K. M., Kee, B. L., Dinner, A. R. and Clark, M. R. (2011). Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat. Immunol. 12, 1212-1220.
35. Matsuda, D., Nakayama, Y., Horimoto, S., Kuga, T., Ikeda, K., Kasahara, K. and Yamaguchi, N. (2006). Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp. Cell Res. 312, 1205-1217.
36. Mera, A., Suga, M., Ando, M., Suda, T. and Yamaguchi, N. (1999). Induction of cell shape changes through activation of the interleukin-3 common beta chain receptor by the RON receptor-type tyrosine kinase. J. Biol. Chem. 274, 15766-15774.
37. Moorhead, G. B., Trinkle-Mulcahy, L. and Ulke-Lemée, A. (2007). Emerging roles of nuclear protein phosphatases. Nat. Rev. Mol. Cell Biol. 8, 234-244.
38. Muraoka-Cook, R. S., Caskey, L. S., Sandahl, M. A., Hunter, D. M., Husted, C., Strunk, K. E., Sartor, C. I., Rearick, W. A., Jr, McCall, W., Sgagias, M. K. et al. (2006). Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Mol. Cell. Biol. 26, 6412-6424.
39. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B. and Cech, T. R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
40. Nakatani, Y. and Ogryzko, V. (2003). Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370, 430-444.
41. Nakayama, Y. and Yamaguchi, N. (2005). Multi-lobulation of the nucleus in prolonged S phase by nuclear expression of Chk tyrosine kinase. Exp. Cell Res. 304, 570-581.
42. Nakayama, Y., Igarashi, A., Kikuchi, I., Obata, Y., Fukumoto, Y. and Yamaguchi, N. (2009). Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway. Exp. Cell Res. 315, 2515-2528.
43. Nakayama, Y., Matsui, Y., Takeda, Y., Okamoto, M., Abe, K., Fukumoto, Y. and Yamaguchi, N. (2012). c-Src but not Fyn promotes proper spindle orientation in early prometaphase. J. Biol. Chem. 287, 24905-24915.
44. Neet, K. and Hunter, T. (1996). Vertebrate non-receptor protein-tyrosine kinase families. Genes Cells 1, 147-169.
45. Ni, C. Y., Murphy, M. P., Golde, T. E. and Carpenter, G. (2001). c-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181.
46. Obata, Y., Fukumoto, Y., Nakayama, Y., Kuga, T., Dohmae, N. and Yamaguchi, N. (2010). The Lyn kinase C-lobe mediates Golgi export of Lyn through conformationdependent ACSL3 association. J. Cell Sci. 123, 2649-2662.
47. Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J. H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M. et al. (2002). Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775-787.
48. Paatero, I., Jokilammi, A., Heikkinen, P. T., Iljin, K., Kallioniemi, O. P., Jones, F. E., Jaakkola, P. M. and Elenius, K. (2012). Interaction with ErbB4 promotes hypoxia-inducible factor-1a signaling. J. Biol. Chem. 287, 9659-9671.
49. Poole, J. C., Andrews, L. G. and Tollefsbol, T. O. (2001). Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269, 1-12.
50. Rio, C., Buxbaum, J. D., Peschon, J. J. and Corfas, G. (2000). Tumor necrosis factoralpha- converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275, 10379-10387.
51. Robinson, G. W., McKnight, R. A., Smith, G. H. and Hennighausen, L. (1995). Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121, 2079-2090.
52. Sardi, S. P., Murtie, J., Koirala, S., Patten, B. A. and Corfas, G. (2006). Presenilindependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127, 185-197.
53. Sato, I., Obata, Y., Kasahara, K., Nakayama, Y., Fukumoto, Y., Yamasaki, T., Yokoyama, K. K., Saito, T. and Yamaguchi, N. (2009). Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J. Cell Sci. 122, 965-975.
54. Schroeder, J. A. and Lee, D. C. (1998). Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 9, 451-464.
55. Schultz, D. C., Ayyanathan, K., Negorev, D., Maul, G. G. and Rauscher, F. J., 3rd (2002). SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16, 919-932.
56. Schulze, W. X., Deng, L. and Mann, M. (2005). Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol. Syst. Biol. 1, 2005.0008.
57. Smith, L. L., Coller, H. A. and Roberts, J. M. (2003). Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5, 474-479.
58. Stover, D. R., Becker, M., Liebetanz, J. and Lydon, N. B. (1995). Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 a. J. Biol. Chem. 270, 15591-15597.
59. Svotelis, A., Bianco, S., Madore, J., Huppé, G., Nordell-Markovits, A., Mes-Masson, A. M. and Gévry, N. (2011). H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERa ligand dependency. EMBO J. 30, 3947- 3961.
60. Tada, J., Omine, M., Suda, T. and Yamaguchi, N. (1999). A common signaling pathway via Syk and Lyn tyrosine kinases generated from capping of the sialomucins CD34 and CD43 in immature hematopoietic cells. Blood 93, 3723-3735.
61. Takahashi, A., Obata, Y., Fukumoto, Y., Nakayama, Y., Kasahara, K., Kuga, T., Higashiyama, Y., Saito, T., Yokoyama, K. K. and Yamaguchi, N. (2009). Nuclear localization of Src-family tyrosine kinases is required for growth factor-induced euchromatinization. Exp. Cell Res. 315, 1117-1141.
62. Tamura, T., Kunimatsu, T., Yee, S. T., Igarashi, O., Utsuyama, M., Tanaka, S., Miyazaki, S., Hirokawa, K. and Nariuchi, H. (2000). Molecular mechanism of the impairment in activation signal transduction in CD4(+) T cells from old mice. Int. Immunol. 12, 1205-1215.
63. Ullrich, A. and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
64. Williams, C. C., Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L. and Jones, F. E. (2004). The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478.
65. Yamaguchi, N. and Fukuda, M. N. (1995). Golgi retention mechanism of beta-1,4- galactosyltransferase. Membrane-spanning domain-dependent homodimerization and association with alpha- and beta-tubulins. J. Biol. Chem. 270, 12170-12176.
66. Yamaguchi, N., Nakayama, Y., Urakami, T., Suzuki, S., Nakamura, T., Suda, T. and Oku, N. (2001). Overexpression of the Csk homologous kinase (Chk tyrosine kinase) induces multinucleation: a possible role for chromosome-associated Chk in chromosome dynamics. J. Cell Sci. 114, 1631-1641.
67. Yarden, Y. and Sliwkowski, M. X. (2001). Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137.
68. Zhu, Y., Sullivan, L. L., Nair, S. S., Williams, C. C., Pandey, A. K., Marrero, L., Vadlamudi, R. K. and Jones, F. E. (2006). Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res. 66, 7991-7998.
69. Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B. and Herman, J. G. (2007). hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 67, 194-201.